Purification process for isolation and commercial production of recombinant TNK-tPA tenecteplase
US10544408B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2015 |
| Grant date | Jan 28, 2020 |
| Priority date | — |
| Expiry date | May 20, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/21068
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel process of isolating and purifying tissue plasminogen activator and its variants more specifically TNK-tPA from CHO cells and describes an industrially applicable, simple, cost effective, robust and highly efficient process of TNK-tPA purification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.